United States · FDA National Drug Code directory
HALOPERIDOL DECANOATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-581_048557ea-f859-f0f2-e063-6294a90af5ab
- Product NDC
- 68001-581
- Form
- INJECTION
- Composition / generic term
- HALOPERIDOL DECANOATE
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230729
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL DECANOATE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-581-41) / 1 mL in 1 VIAL, SINGLE-DOSE · 68001-581-41
- 5 VIAL, SINGLE-DOSE in 1 CARTON (68001-581-48) / 1 mL in 1 VIAL, SINGLE-DOSE · 68001-581-48
- 10 VIAL, SINGLE-DOSE in 1 CARTON (68001-581-82) / 1 mL in 1 VIAL, SINGLE-DOSE · 68001-581-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →